Clinical Observation of the Relationship between Retinal Vein Occlusion and Homocysteine
10.3969/j.issn.1671-7414.2018.01.030
- VernacularTitle:视网膜静脉阻塞患者血清同型半胱氨酸水平检测的临床意义
- Author:
Yu ZHANG
1
;
Qing-Yun QUAN
;
Juan SUN
;
Gui-Yun ZHANG
Author Information
1. 武警陕西省总队医院干部病房
- Keywords:
retinal vein occlusion;
homocysteine;
risk factors
- From:
Journal of Modern Laboratory Medicine
2018;33(1):118-120
- CountryChina
- Language:Chinese
-
Abstract:
Objective The discussion of plasma homocysteine in retinal vein occlusion (homocysteine,Hcy) level changes,to study whether elevated plasma Hcy is a risk factor for RVO,and provide objective basis for the prevention and treatment of the disease.Methods A case control study of 65 cases were collected after unified ophthalmic examination standard diagnosis of RVO and after disease screening criteria of patients as case group [central retinal vein occlusion (CRVO) in 46 patients,branch retinal vein occlusion (BRVO) in 19 healthy people],and no previous history of retinal vascular diseases.65 cases as the control group,the two groups showed no significant difference in age and sex.The content of plasma Hey after statistical comparison detection.Results The mean plasma Hcy in the RVO case group was significantly higher than that in the control group (t=6.192,P＜0.05).There was no significant difference in plasma Hey index between CRVO and BRVO patients in the case group (t=1.536,P＞0.05).Conclusion Plasma Hcy is a risk factor for RVO,and a drug that reduces Hcy can be used in the prevention and treatment of RVO.
